Unihealth Hospitals Ltd
Healthcare | Small Cap
Unihealth Hospitals demonstrates a mixed financial performance. Revenue and asset growth have been strong, indicating expansion and market acceptance. Profitability metrics such as gross profit margin and operating margin are robust. However, certain areas like earnings per share growth and net income growth show inconsistencies. The company exhibits strengths in managing debt and operational efficiency, but working capital management needs improvement. Unihealth's ability to maintain revenue growth while optimizing profitability will be crucial for its sustained success in the competitive healthcare sector.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio6.00
- Financial Ratio8.40
- Profitability Ratio7.70
- Efficiency Ratio2.00
- Coverage Ratio8.00
- Solvency Ratio9.09
- Liquidity Ratio0.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Unihealth Hospitals demonstrates a mixed financial performance. Revenue and asset growth have been strong, indicating expansion and market acceptance. Profitability metrics such as gross profit margin and operating margin are robust. However, certain areas like earnings per share growth and net income growth show inconsistencies. The company exhibits strengths in managing debt and operational efficiency, but working capital management needs improvement. Unihealth's ability to maintain revenue growth while optimizing profitability will be crucial for its sustained success in the competitive healthcare sector.
Overall Valuation Score
P/E RATIO (TTM)
N/A
Industry Median
36.13
Small Cap Median
35.79
P/B RATIO
3.77
Industry Median
6.08
Small Cap Median
6.08
P/S RATIO
N/A
Industry Median
5.75
Small Cap Median
5.17
Others
PEG RATIO
0.00
EV/EBITDA RATIO
22.51
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹305 as on Feb 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Unihealth exhibits mixed growth trends. High revenue and asset growth are offset by inconsistent earnings per share and net income growth. While the company is expanding, translating this growth into consistent profitability remains a challenge. Focus on sustainable and profitable expansion is essential.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Growth Rate | 250 | 71.43 | 16.67 | 28.57 | 0 |
| Earnings Per Share (EPS) Growth | N/A | N/A | N/A | N/A | N/A |
| Asset Growth Rate | N/A | 12.07 | 20 | 41.03 | 20 |
| Net Income Growth Rate | N/A | N/A | N/A | N/A | N/A |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Unihealth's financial metrics reflect strong earnings per share, book value, and capital expenditure management. This indicates a solid financial foundation and effective use of resources. This positive trend supports investor confidence and provides a basis for future growth.
| Financial Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | N/A | N/A | N/A | N/A | N/A |
| Cash Earnings Per Share (Cash EPS) | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 100 | 140 | 270 | 56.67 | 68.67 |
| Dividend Per Share (DPS) | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures (CapEx) | 0 | 0 | 0 | 0 | 0 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Unihealth demonstrates strong profitability, supported by high gross profit and operating margins. Return on assets and net margin are also at good levels. While return on capital employed and return on equity are average, the overall profitability picture is positive. Focus on sustaining these margins will be vital for future financial success.
| Profitability Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A |
| Return on Capital Employed (ROCE) | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (ROE) | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (ROA) | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency metrics suggest notable issues in asset utilization. The company may face challenges in optimizing its working capital and converting resources into revenue. Addressing these inefficiencies could improve overall financial performance and profitability.
| Efficiency Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover Ratio | N/A | N/A | N/A | N/A | N/A |
| Receivables Turnover Ratio | N/A | N/A | N/A | N/A | N/A |
| Days Sales in Inventory Ratio | N/A | N/A | N/A | N/A | N/A |
| Receivable Days | N/A | N/A | N/A | N/A | N/A |
| Capital Turnover Ratio | 0 | 0 | 0 | 0 | 0 |
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Unihealth demonstrates a good capacity to cover its interest expenses. This indicates a healthy financial cushion and reduces the risk of financial distress. Maintaining this level of coverage is vital for ensuring long-term solvency and financial health.
| Coverage Ratios | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Interest Coverage Ratio | 0.5 | 6 | 2 | 3.25 | 5.67 | 9.5 |
| Equity Dividend Coverage Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Interest Coverage Ratio
Unihealth Hospitals exhibits a strong solvency position. This indicates a reduced risk of financial distress and suggests the company is well-positioned to manage its long-term obligations. The low debt-to-equity ratio reflects conservative financing strategies and a healthy balance sheet.
| Solvency Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 | 0 | 0 |
| Debt to Equity Ratio | 0 | 0 | 0 | 0 | 0 |
| Equity Ratio | 1 | 1 | 1 | 1 | 1 |
| Debt To Asset Ratio | 0 | 0 | 0 | 0 | 0 |
Debt Ratio
Debt to Equity Ratio
Interest Coverage Ratio
The liquidity position cannot be determined, as the underlying calculations are absent. A comprehensive liquidity assessment would involve examining the company's capacity to meet its short-term obligations.
| Liquidity Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Cash Ratio | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow Ratio | N/A | N/A | N/A | N/A | N/A |
Current Ratio
Quick Ratio
Cash Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Unihealth Hospitals Ltd | 5.76 | N/A | Neutral | 18.00 | 1.52 | 15.00 |
The management of Unihealth Hospitals Ltd demonstrates a mixed performance. The company exhibits strong profit growth and improving operating profit margins, reflecting effective operational management. A significant reduction in borrowings indicates prudent financial management. However, high debtor days and a fluctuating cash conversion cycle suggest inefficiencies in working capital management. Overall, the financial performance is trending positively, but management should focus on enhancing operational efficiency.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Strong Profit Growth | 28% (3Y), 35% (TTM) | Profit growth is strong. |
| Improving OPM | 37% (TTM) | Operational efficiency is improving. | |
| Reduced Borrowings | ₹ 10 Cr (Sep 2024) | Leverage is under control. | |
| CONS | High Debtor Days | 251 (Mar 2024) | Collection period is lengthy. |
| Fluctuating Cash Conversion Cycle | 188 (Mar 2023), 235 (Mar 2024) | Working capital management is inconsistent. |
Financial Performance & Growth
Unihealth Hospitals demonstrates a positive trend in financial performance. The compounded profit growth shows a strong upward trajectory with 28% over 3 years and 35% TTM. OPM is also improving, with the latest TTM figure at 37%. However, sales growth is moderate, with TTM sales growth at 11%. Quarterly results show consistent sales and operating profit, indicating stability. Other income contributes marginally to the net profit.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|
| Sales (₹ Cr) | 22 | 26 | 37 | 44 | 49 | 50 |
| Sales Growth (%) | 17.90% | 40.52% | 19.28% | 10.97% | ||
| OPM (%) | 10% | 25% | 31% | 31% | 36% | 37% |
Capital Efficiency & Returns
The capital efficiency of Unihealth Hospitals is mixed. While the current ROCE of 20.25% indicates reasonable capital utilization, the Return on Equity (ROE) is 7.87%.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| ROCE (%) | 14% | 20% | 22% | 20% |
Financial Health & Prudence
Unihealth Hospitals shows signs of improving financial health. Borrowings have decreased from ₹41 Cr in Mar 2020 to ₹10 Cr in Sep 2024, indicating better debt management. The interest coverage ratio can be inferred from the profit and loss statement, showing that operating profit comfortably covers interest expenses. The company does not pay dividends, retaining profits for reinvestment. The dividend payout is consistently 0%.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Borrowings (₹ Cr) | 41 | 39 | 38 | 39 | 15 | 10 |
Strategic & Operational Indicators
Unihealth Hospitals faces some challenges in working capital management. Debtor days have increased from 206 in Mar 2020 to 251 in Mar 2024, indicating a longer time to collect receivables. Inventory days have fluctuated, and payable days have decreased significantly. These factors contribute to a fluctuating cash conversion cycle.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Debtor Days | 206 | 198 | 180 | 228 | 251 |
| Inventory Days | 50 | 86 | 78 | 98 | 88 |
| Payable Days | 382 | 91 | 79 | 137 | 104 |
The risk assessment for Unihealth Hospitals Ltd is rated as Orange, indicating moderate risk. The company exhibits positive trends such as decreasing borrowings and improving profitability, which mitigate some risks. However, high debtor days and fluctuating cash conversion cycles raise concerns about working capital management. Additionally, the absence of dividend payouts, while potentially beneficial for reinvestment, could be seen as a risk by some investors seeking regular income. The concentration of promoter holding also presents a risk if not managed effectively. Overall, the company demonstrates a mix of strengths and weaknesses that warrant careful monitoring.
Off-balance sheet exposure quantification
There is no specific data available to quantify off-balance sheet exposures.
Contingent liability evaluation
There is no specific data available regarding contingent liabilities.
Accounting quality red flags
The financial statements appear consistent, and there are no sudden or unexplained changes in accounting practices.
Regulatory compliance cost trends
There is no specific data available regarding regulatory compliance cost trends.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe